Evans syndrome: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Evans syndrome}} | {{Evans syndrome}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} {{F.Z}} | ||
{{SK}} Low grade fibromyxoid sarcoma; Evan's syndrome; Evans' syndrome; AHA/Immune TP; Coombs positive hemolytic anemia; IGG autoimmune hemolytic anemia | {{SK}} Low grade fibromyxoid sarcoma; Evan's syndrome; Evans' syndrome; AHA/Immune TP; Coombs positive hemolytic anemia; IGG autoimmune hemolytic anemia |
Latest revision as of 23:17, 22 July 2021
For patient information click here
Evans syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Evans syndrome On the Web |
American Roentgen Ray Society Images of Evans syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2] Fizza Zulfiqar, MD[3]
Synonyms and keywords: Low grade fibromyxoid sarcoma; Evan's syndrome; Evans' syndrome; AHA/Immune TP; Coombs positive hemolytic anemia; IGG autoimmune hemolytic anemia
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Evans syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies